Growth Metrics

Palvella Therapeutics (PVLA) Change in Acquisitions & Divestments (2018 - 2024)

Palvella Therapeutics has reported Change in Acquisitions & Divestments over the past 4 years, most recently at $6.3 million for Q4 2022.

  • Quarterly Change in Acquisitions & Divestments changed N/A to $6.3 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $28.2 million through Dec 2022, changed N/A year-over-year, with the annual reading at $35.0 million for FY2023, 24.14% up from the prior year.
  • Change in Acquisitions & Divestments was $6.3 million for Q4 2022 at Palvella Therapeutics, down from $17.0 million in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $53.5 million in Q3 2018 and troughed at -$53.5 million in Q4 2019.
  • The 4-year median for Change in Acquisitions & Divestments is $15.8 million (2020), against an average of $9.5 million.
  • Year-over-year, Change in Acquisitions & Divestments plummeted 51.19% in 2019 and then skyrocketed 898.35% in 2020.
  • A 4-year view of Change in Acquisitions & Divestments shows it stood at -$42.4 million in 2018, then dropped by 25.99% to -$53.5 million in 2019, then soared by 129.45% to $15.8 million in 2020, then plummeted by 60.0% to $6.3 million in 2022.
  • Per Business Quant, the three most recent readings for PVLA's Change in Acquisitions & Divestments are $6.3 million (Q4 2022), $17.0 million (Q3 2022), and $4.8 million (Q2 2022).